While weather events and pandemics are still very real concerns, the most insidious threats today are digital. To make things ...

Travere Therapeutics, Inc., today announced that the Company will present three abstracts on the effect of FILSPARI (sparsentan) in rare kidney disease at the upcoming International Podocyte ...